Comparative risk of incident malignancies in rheumatoid arthritis patients treated with Janus kinase inhibitors or bDMARDs: observational data from the German RABBIT register

Journal:
Annals of the Rheumatic Diseases
Published:
DOI:
10.1016/j.ard.2025.05.014
Affiliations:
7
Authors:
12
Go to article
Institutions Authors Share
German Rheumatism Research Centre Berlin (DRFZ), Germany
7.000000
 0.58
non-affiliated author contributions, Germany
2.000000
 0.17
Asklepios Harzklinik Goslar, Germany
1.000000
 0.08
Heinrich Heine University Düsseldorf (HHU), Germany
1.000000
 0.08
University Medicine Greifswald, Germany
0.500000
 0.04
Charité - University Medicine Berlin, Germany
0.500000
 0.04
Interested in Clinical Sciences?